Immunohistochemistry (IHC) Market Report 2024: Strategies And Recent Developments

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2404

The Business Research Company offers in-depth market insights through Immunohistochemistry (IHC) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The immunohistochemistry (ihc) market size has grown strongly in recent years. It will grow from $2.43 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements..

The immunohistochemistry (ihc) market size is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization.. Major trends in the forecast period include multiplex ihc techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Market Segmentation:
The immunohistochemistry (ihc) market covered in this report is segmented -

1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Major Driver - Increase In Chronic Diseases Prevalence Boosts Immunohistochemistry (IHC) Market Growth
The increase in the prevalence of chronic diseases is expected to propel the immunohistochemistry (IHC) market going forward. Chronic diseases refer to clinical conditions that last for three months or more extended periods and usually can be controlled but not cured. Immunohistochemistry helps in diagnosing chronic diseases such as cancer, cardiovascular disorders, and others due to its various advantages, such as its specificity, sensitivity (used to detect specific antigens), rapid results, and others. For instance, in 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people have diabetes which equals 11.3% of the United States population. Therefore, an increase in the prevalence of chronic diseases is driving the growth of the immunohistochemistry (IHC) market.

Competitive Landscape:
Major companies operating in the immunohistochemistry (ihc) market report are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc. .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Top Trend - Technological Advancements Propel Innovation In Immunohistochemistry (IHC) Market
Technological advancement is the key trend in the immunohistochemistry (IHC) market. Major companies operating in the market are focused on developing technologically advanced products to strengthen their position in the market. For instance, in April 2021, Akoya Biosciences, Inc, a US-based company operating in end-to-end solutions for high-parameter tissue analysis, introduced its new multiplex detection kits based on Opal multiplex technology known as Akoya's Opal Multiplex Detection Kits. The opal multiplex technique is a methodology for detecting multiple biomarkers in one section of tissue that encompasses iterative single staining and heating-mediated removal of the primary stain. Akoya's Opal Multiplex Detection Kits provide phenotypic scoring using signal amplification, low sample and reagent consumption, can measure 3 to 8 IHC targets and nuclear stains, and other advanced features.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Immunohistochemistry (IHC) Market Characteristics
3. Immunohistochemistry (IHC) Market Trends And Strategies
4. Immunohistochemistry (IHC) Market - Macro Economic Scenario
5. Immunohistochemistry (IHC) Market Size And Growth
…..
27. Immunohistochemistry (IHC) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.